Vertex Pharmaceuticals Inc. buy Bank of America Co.
Start price
19.12.24
/
50%
€377.00
Target price
19.12.25
€503.63
Performance (%)
3.34%
End price
20.12.25
€389.60
Summary
This prediction ended on 20.12.25 with a price of €389.60. With a performance of 3.34%, the BUY prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc. closed with a slight gain. Bank_of_America_Co_ has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.794% | 1.794% | 30.146% |
| iShares Core DAX® | 0.437% | 5.897% | 8.047% |
| iShares Nasdaq 100 | 1.057% | 0.920% | 28.466% |
| iShares Nikkei 225® | 1.769% | 1.228% | 47.574% |
| iShares S&P 500 | 0.368% | 1.920% | 23.200% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Bank of America Co. from $545.00 to $522.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€432.95
10.03.26
10.03.26
€514.40
10.03.27
10.03.27
0.57%
09:30
09:30
Stopped prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€456.50
31.03.25
31.03.25
€523.00
31.03.26
31.03.26
-15.75%
01.04.26
01.04.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€444.75
14.10.24
14.10.24
€496.10
14.10.25
14.10.25
-20.33%
15.10.25
15.10.25